Evercore ISI analyst Vijay Kumar raised the firm’s price target on Illumina (ILMN) to $142 from $132 and keeps an Outperform rating on the shares. Illumina’s Q3 performance exceeded expectations with total revenues about 2% above Wall Street estimates, driven by strong operational management and cost efficiencies, the analyst tells investors in a research note. The firm added that challenges in China persist due to export restrictions, impacting instrument revenues by 54%, despite recent approvals to manufacture select instruments locally.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
